Hadassah Ein Karem Hospital; Oncology Dept
Jerusalem, Israel
Hospital in Jerusalem
Kalman Ya'akov Man St, Jerusalem
1,029 (more than) Beds
About Hadassah Ein Karem Hospital; Oncology Dept
Hadassah Medical Center is an Israeli medical organization established in 1934 that operates two university hospitals at Ein Kerem and Mount Scopus in Jerusalem as well as schools of medicine, dentistry, nursing, and pharmacology affiliated with the Hebrew University of Jerusalem.
There are 1,029 (more than) beds in Hadassah Ein Karem Hospital; Oncology Dept.
- Top Sponsors
- Top Collaborators
- Trials By Phase
- Recruitment Status
- Top Conditions
- Intervention Types
- Top Intervention Names
- Trials By Gender
Lead Sponsor
# Trials
Hoffmann-La Roche
14
Alpha Tau Medical LTD.
3
Genentech, Inc.
1
Clinical Trials at Hadassah Ein Karem Hospital; Oncology Dept
During the past decade, Hadassah Ein Karem Hospital; Oncology Dept conducted 11 clinical trials. In the 10-year time frame, 11 clinical trials started and 10 clinical trials were completed, i.e. on
average, 90.9% percent of trials that started reached the finish line to date. In the past 5 years, 6 clinical trials started and 4 clinical trials were completed. i.e. 66.7%
of trials that started reached the finish line.
Trials List
Trail ID
Brief Title
Start Date
Completion Date
Status
Enrollment
A Study of Xeloda (Capecitabine) Plus Oxaliplatin in Patients With Colon Cancer
2003-04-18
2011-04-21
Completed
1,886
A Study of Pertuzumab in Combination With Herceptin in Patients With HER2 Positive Breast Cancer.
2006-06-26
2014-09-22
Completed
417
A Study to Compare Subcutaneous (SC) Versus Intravenous (IV) Administration of Herceptin (Trastuzumab) in Women With Human Epidermal Growth Factor Receptor (HER) 2-Positive Early Breast Cancer
2009-10-16
2017-01-24
Completed
596
A Study on the Correlation Between Tarceva (Erlotinib) - Induced Rash and Efficacy in EGFR Mutated Participants With Advanced Non-Small Cell Lung Cancer Receiving First-Line Therapy
2011-05-23
2016-12-20
Completed
60
A Study of Vemurafenib in Participants With Metastatic Melanoma
2011-03-01
2016-02-24
Completed
3,219
A Study of Pertuzumab in Combination With Trastuzumab (Herceptin) and a Taxane in First-Line Treatment in Participants With Human Epidermal Growth Factor 2 (HER2)-Positive Advanced Breast Cancer
2012-06-01
2019-09-20
Completed
1,436
A Study of Subcutaneous At Home Administration of Trastuzumab (Herceptin) in Participants With Human Epidermal Growth Factor Receptor 2-positive (HER2+) Early Breast Cancer (eBC)
2013-11-19
2017-07-19
Completed
102
A Study of Atezolizumab in Combination With Carboplatin Plus (+) Nab-Paclitaxel Compared With Carboplatin+Nab-Paclitaxel in Participants With Stage IV Non-Squamous Non-Small Cell Lung Cancer (NSCLC)
2015-04-16
2021-01-18
Completed
723
Clinical Trials Sponsors and Collaborators
In terms of collaborators to trials, out of the total clinical trials conducted in "Hadassah Ein Karem Hospital; Oncology Dept"
#1 collaborator was "Clalit Health Services" with 1 trials as a collaborator and "European Organisation for Research and Treatment of Cancer - EORTC" with 1 trials as a collaborator. Other collaborators include -2 different institutions and companies that were
collaborators in the rest 2 trials.
Clinical Trials Conditions at Hadassah Ein Karem Hospital; Oncology Dept
According to Clinical.Site data, the most researched conditions in "Hadassah Ein Karem Hospital; Oncology Dept" are
"Breast Cancer" (3 trials), "Head and Neck Squamous Cell Carcinoma" (2 trials), "Skin Cancer" (2 trials), "Breast Neoplasms" (1 trials) and "Carcinoma, Non-Squamous Non-Small Cell Lung" (1 trials). Many other conditions were trialed in "Hadassah Ein Karem Hospital; Oncology Dept" in a lesser frequency.
Clinical Trials Intervention Types at Hadassah Ein Karem Hospital; Oncology Dept
Most popular intervention types in "Hadassah Ein Karem Hospital; Oncology Dept" are "Drug" (16 trials), "Device" (3 trials) and "Other" (2 trials). Other intervention types were less common.
The name of intervention was led by "Atezolizumab" (4 trials), "Docetaxel" (3 trials), "Paclitaxel" (2 trials), "Pertuzumab" (2 trials) and "Placebo" (2 trials). Other intervention names were less common.
Clinical Trials Genders at Hadassah Ein Karem Hospital; Oncology Dept
The vast majority of trials in "Hadassah Ein Karem Hospital; Oncology Dept" are
16 trials for "All" genders and 2 trials for "Female" genders.
Clinical Trials Status at Hadassah Ein Karem Hospital; Oncology Dept
Currently, there are NaN active trials in "Hadassah Ein Karem Hospital; Oncology Dept".
1 are not yet recruiting,
4 are recruiting,
1 are Active, not recruiting,
and undefined are Enrolling by invitation.
In total, there were 12 completed trials in Hadassah Ein Karem Hospital; Oncology Dept,
undefined suspended trials,
and undefined terminated clinical trials to date.
Out of the total trials that were conducted in Hadassah Ein Karem Hospital; Oncology Dept, 1 "Phase 1"
clinical trials were conducted, 3 "Phase 2" clinical
trials and 11 "Phase 3" clinical trials were conducted as
well. "Phase 4" trials included 0 trials, and there were
also 3 trials that are defined as “Not Applicable".